Folgen
Judith L. Fridovich-Keil
Judith L. Fridovich-Keil
Professor of Human Genetics, Emory University School of Medicine
Bestätigte E-Mail-Adresse bei emory.edu
Titel
Zitiert von
Zitiert von
Jahr
A chicken-yeast chimeric β-tubulin protein is incorporated into mouse microtubules in vivo
JF Bond, JL Fridovich-Keil, L Pillus, RC Mulligan, F Solomon
Cell 44 (3), 461-468, 1986
2081986
Crystallographic Evidence for Tyr 157 Functioning as the Active Site Base in Human UDP−Galactose 4-Epimerase,
JB Thoden, TM Wohlers, JL Fridovich-Keil, HM Holden
Biochemistry 39 (19), 5691-5701, 2000
1872000
Classical galactosemia and mutations at the galactose‐1‐phosphate uridyl transferase (GALT) gene
L Tyfield, J Reichardt, J Fridovich‐Keil, DT Croke, LJ Elsas, W Strobl, ...
Human mutation 13 (6), 417-430, 1999
1861999
The human galactose-1-phosphate uridyltransferase gene
ND Leslie, EB Immerman, JE Flach, M Florez, JL Fridovich-Keil, LJ Elsas
Genomics 14 (2), 474-480, 1992
1711992
Human UDP-galactose 4-epimerase: accommodation of UDP-N-acetylglucosamine within the active site
JB Thoden, TM Wohlers, JL Fridovich-Keil, HM Holden
Journal of Biological Chemistry 276 (18), 15131-15136, 2001
1562001
Disorders of galactose metabolism
GT Berry
Rosenberg's molecular and genetic basis of neurological and psychiatric …, 2015
1552015
Ovarian function in girls and women with GALT-deficiency galactosemia
JL Fridovich-Keil, CS Gubbels, JB Spencer, RD Sanders, JA Land, ...
Journal of inherited metabolic disease 34, 357-366, 2011
1412011
A common mutation associated with the Duarte galactosemia allele.
LJ Elsas, PP Dembure, S Langley, EM Paulk, LN Hjelm, J Fridovich-Keil
American journal of human genetics 54 (6), 1030, 1994
1241994
Galactosemia: a strategy to identify new biochemical phenotypes and molecular genotypes.
LJ Elsas, S Langley, E Steele, J Evinger, JL Fridovich-Keil, A Brown, ...
American journal of human genetics 56 (3), 630, 1995
1211995
Galactosemia
JL Fridovich-Keil
Elsevier, 2017
1182017
Diversity of approaches to classic galactosemia around the world: a comparison of diagnosis, intervention, and outcomes
PP Jumbo-Lucioni, K Garber, J Kiel, I Baric, GT Berry, A Bosch, A Burlina, ...
Journal of inherited metabolic disease 35, 1037-1049, 2012
1022012
Galactosemia: the good, the bad, and the unknown
JL Fridovich‐Keil
Journal of cellular physiology 209 (3), 701-705, 2006
1022006
Newborn screening for galactosemia in the United States: looking back, looking around, and looking ahead
BM Pyhtila, KA Shaw, SE Neumann, JL Fridovich-Keil
JIMD reports, volume 15, 79-93, 2015
1002015
Epimerase-deficiency galactosemia is not a binary condition
KK Openo, JM Schulz, CA Vargas, CS Orton, MP Epstein, RE Schnur, ...
The American Journal of Human Genetics 78 (1), 89-102, 2006
982006
Inducible proteins binding to the murine thymidine kinase promoter in late G1/S phase.
QP Dou, JL Fridovich-Keil, AB Pardee
Proceedings of the National Academy of Sciences 88 (4), 1157-1161, 1991
971991
Identification and characterization of a mutation, in the human UDP-galactose-4-epimerase gene, associated with generalized epimerase-deficiency galactosemia
TM Wohlers, NC Christacos, MT Harreman, JL Fridovich-Keil
The American Journal of Human Genetics 64 (2), 462-470, 1999
931999
A yeast expression system for human galactose-1-phosphate uridylyltransferase.
JL Fridovich-Keil, S Jinks-Robertson
Proceedings of the National Academy of Sciences 90 (2), 398-402, 1993
911993
Differential roles of the Leloir pathway enzymes and metabolites in defining galactose sensitivity in yeast
KL Ross, CN Davis, JL Fridovich-Keil
Molecular genetics and metabolism 83 (1-2), 103-116, 2004
872004
Structural analysis of the Y299C mutant of Escherichia coli UDP-galactose 4-epimerase: teaching an old dog new tricks
JB Thoden, JM Henderson, JL Fridovich-Keil, HM Holden
Journal of Biological Chemistry 277 (30), 27528-27534, 2002
812002
Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: a pilot study
BJ Dezube, ML Sherman, JL Fridovich-Keil, J Allen-Ryan, AB Pardee
Cancer Immunology, Immunotherapy 36, 57-60, 1993
801993
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20